PadraicO'MalleyMD

Clinical Trials

• Intravesical BCG vs GEMDOCE in NMIBC Start of enrollment: 2023 Feb 07

  Recruiting

  Phase 3

• A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Start of enrollment: 2022 Jul 07

  Recruiting

  Phase 2

• Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304) Start of enrollment: 2021 Apr 21

  Active, not recruiting

  Phase 3

• Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer Start of enrollment: 2020 Mar 18

  Recruiting

  Phase 2

• S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Start of enrollment: 2017 Feb 24

  Active, not recruiting

  Phase 3

• Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study Start of enrollment: 2019 Jun 07

  Active, not recruiting

  Phase 3

• Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial Start of enrollment: 2021 Mar 08

  Recruiting

  Phase 3

• Join now to see all